Assessment of left ventricular systolic and diastolic function by tissue Doppler analysis in patients with hypertension with or without hyperuricemia

Blood Pressure Monitoring

Volumn 13, Issue 2, 2008, Pages 79-84

  Tavil, Yusuf ^a   Kaya, Mehmet Gungor ^a   Sen, Nihat ^a   Tacoy, Gulten ^a   Okyay, Kaan ^a   Yazc, Huseyin Ugur ^a   Yalcin, Mehmet Ridvan ^a   Cengel, Atiye ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Hypertension; Hyperuricemia; Tissue Doppler echocardiography; Ventricular function

Indexed keywords

CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE FILLING; HEART PERFORMANCE; HUMAN; HYPERTENSION; HYPERURICEMIA; MALE; MEDICAL INSTRUMENTATION; PRIORITY JOURNAL; RISK FACTOR; SMOKING HABIT; SYSTOLIC BLOOD PRESSURE;

AGED; CASE-CONTROL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HUMANS; HYPERTENSION; HYPERURICEMIA; MALE; MIDDLE AGED; MITRAL VALVE; VENTRICULAR DYSFUNCTION, LEFT;

EID: 40949093146     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBP.0b013e3282faa732     Document Type: Article

References (30)

1. Fessel WJ. High uric acid as an indicator of cardiovascular disease. Independence from obesity. Am J Med 1980; 68:401-404.
2. Bengtsson C, Lapidus L, Stendahl C, Waldenstrom J. Hyperuricaemia and risk of cardiovascular disease and overall death. A 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Acta Med Scand. 1988; 224:549-555.
3. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, et al. Relationship of uric acid concentration to cardiovascular risk factors in young men. The role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20:975-980.
4. Vuorinen-Markkola H, Yki-Järvinen H. Hyperuricemia and insulin resistance. J Clin Endocrinol Metab 1994; 78:25-29.
5. Rathmann W, Funkhouser E, Dyer AR, Roseman JM. Relations of hyperuricemia with the various components of the insulin resistance syndrome in young black and white adults: the CARDIA study. Coronary Artery Risk Development in Young Adults. Ann Epidemiol 1998; 8:250-261.
6. Lee J, Sparrow D, Vokonas PS, Landsberg L, Weiss ST. Uric acid and coronary heart disease risk: evidence for a role of uric acid in the obesityinsulin resistance syndrome. The Normative Aging Study. Am J Epidemiol 1995; 142:288-294.
7. Rathmann W, Hauner H, Dannehl K, Gries FA. Association of elevated serum uric acid with coronary heart disease in diabetes mellitus. Diabetes Metab 1993; 19:159-166.
8. Selby JV, Friedman GD, Quesenberry CP Jr. Precursors of essential hypertension: pulmonary function, heart rate, uric acid, serum cholesterol, and other serum chemistries. Am J Epidemiol 1990; 131:1017-1127.
9. Jossa F, Farinaro E, Panico S, Krogh V, Celentano E, Galasso R, et al. Serum uric acid and hypertension: The Olivetti heart-study. J Hum Hypertens 1994; 8:677-681.
10. Taniguchi Y, Hayashi T, Tsumura K, Endo G, Fujii S, Okada K. Serum uric acid and the risk for hypertension and Type 2 diabetes in Japanese men: the Osaka Health Survey. J Hypertens 2001; 19:1209-1215.
11. Inouye I, Massie B, Loge D, Topic N, Silverstein D, Simpson P, et al. Abnormal left ventricular filling: an early finding in mild to moderate systemic hypertension. Am J Cardiol 1984; 53:120-126.
12. Gardin JM, Drayer JI, Weber M, Rohan MK, Knoll M, Shu VW, et al. Doppler echocardiographic assessment of left ventricular systolic and diastolic function in mild hypertension. Hypertension 1987; 9:90-96.
13. Ganau A, Devereux RB, Roman MJ, de Simone G, Pickering TG, Saba PS, et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol. 1992; 19:1550-1558.
14. Tarazi RC. The heart in hypertension. N Engl J Med 1985; 312:308-309.
15. Lavie CJ, Messerli FH. Cardiovascular adaptation to obesity and hypertension. Chest 1986; 90:275-279.
16. Anon 1999. World Health Organization-International Society of Hypertension guidelines for the management of hypertension. J Hypertens 1999; 17:151-183.
17. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977; 55:613-618.
18. Appleton CP, Jensen JL, Hatle LK, Oh JK. Doppler evaluation of left and right ventricular diastolic function: a technical guide for obtaining optimal flow velocity recordings. J Am Soc Echocardiogr 1997; 10:271-292.
19. Simonson JS, Schiller NB. Descent of the base of the left ventricle: an echocardiographic index of the left ventricular functions. J Am Soc Echocardiogr 1989; 2:25-35.
20. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ, et al. New index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function - a study in normals and dilated cardiomyopathy. J Cardiol 1995; 26:357-366.
21. Tei C, Nishimura RA, Seward JB, Tajik AJ. Noninvasive Doppler-derived myocardial performance index: correlation with simultaneous measurements of cardiac catheterization measurements. J Am Soc Echocardiogr 1997; 10:169-178.
22. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB. Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. J Am Coll Cardiol 1996; 28:658-664.
23. Breckenridge A. Hypertension and hyperuricaemia. Lancet 1966; 1:15-18.
24. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18:858-865.
25. Mazzali M, Kanellis J, Han L, Feng L, Xia YY, Chen Q, et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressureindependent mechanism. Am J Physiol Renal Physiol 2002; 282:991-997.
26. Waring WS, Webb DJ, Maxwell SR. Effect of local hyperuricemia on endothelial function in the forearm vascular bed. Br J Clin Pharmacol 2000; 49:511.
27. Gonick HC, Rubini MD, Gleason IO, Sommers SC. The renal lesion in gout. Arch Intern Med 1965; 62:667-674.
28. Gordon TP, Terkeltaub R, Ginsberg MH. Gout: crystal-induced inflammation. In: Gallin JI, Goldstein IM, Snyderman R, editors. Inflammation: basic principles and clinical correlates. New York: Raven; 1988:775-783.
29. Iwashima Y, Horio T, Kamide K, Rakugi H, Ogihara T, Kawano Y. Uric acid, left ventricular mass index, and risk of cardiovascular disease in essential hypertension. Hypertension 2006; 47:195-202.
30. Kurata A, Shigematsu Y, Higaki J. Sex-related differences in relations of uric acid to left ventricular hypertrophy and remodeling in Japanese hypertensive patients. Hypertens Res 2005; 28:133-139.